These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28220029)

  • 1. A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-
    Liu R; Das B; Xiao W; Li Z; Li H; Lee K; He JC
    J Am Soc Nephrol; 2017 Jul; 28(7):2133-2143. PubMed ID: 28220029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular HIPK2 is a key contributor to renal fibrosis.
    Xiao W; E J; Bao L; Fan Y; Jin Y; Wang A; Bauman D; Li Z; Zheng YL; Liu R; Lee K; He JC
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32701510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.
    Chang X; Zhen X; Liu J; Ren X; Hu Z; Zhou Z; Zhu F; Ding K; Nie J
    Kidney Int; 2017 Sep; 92(3):612-624. PubMed ID: 28318631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
    Jin Y; Ratnam K; Chuang PY; Fan Y; Zhong Y; Dai Y; Mazloom AR; Chen EY; D'Agati V; Xiong H; Ross MJ; Chen N; Ma'ayan A; He JC
    Nat Med; 2012 Mar; 18(4):580-8. PubMed ID: 22406746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Homeodomain-Interacting Protein Kinase 2 in the Pathogenesis of Tissue Fibrosis in Keloid-Derived Keratinocytes.
    Zhao YX; Zhang GY; Wang AY; Chen YH; Lin DM; Li QF
    Ann Plast Surg; 2017 Dec; 79(6):546-551. PubMed ID: 29053518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
    You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX
    J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA
    Wang P; Luo ML; Song E; Zhou Z; Ma T; Wang J; Jia N; Wang G; Nie S; Liu Y; Hou F
    Sci Transl Med; 2018 Oct; 10(462):. PubMed ID: 30305452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of HIPK2 attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
    He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
    Biomed Pharmacother; 2017 Jan; 85():575-581. PubMed ID: 27890429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-β1-Smad3 pathway.
    Wang HW; Shi L; Xu YP; Qin XY; Wang QZ
    Ren Fail; 2016 Jul; 38(6):945-51. PubMed ID: 27050799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.
    Meng XM; Huang XR; Chung AC; Qin W; Shao X; Igarashi P; Ju W; Bottinger EP; Lan HY
    J Am Soc Nephrol; 2010 Sep; 21(9):1477-87. PubMed ID: 20595680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses.
    Overstreet JM; Samarakoon R; Cardona-Grau D; Goldschmeding R; Higgins PJ
    FASEB J; 2015 Apr; 29(4):1258-68. PubMed ID: 25480384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
    Zhang Y; Meng XM; Huang XR; Lan HY
    Clin Sci (Lond); 2018 Jul; 132(13):1403-1415. PubMed ID: 29875262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
    Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
    Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.
    Huang Y; Tong J; He F; Yu X; Fan L; Hu J; Tan J; Chen Z
    Int J Mol Med; 2015 Feb; 35(2):311-8. PubMed ID: 25421593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.
    Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF
    J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.